India has approved its first nasal Covid vaccine. Made by Bharat Biotech, iNCOVACC is administered in the form of drops and stimulates an immune response in the tissues that line the nasal cavity.

Biotech Startup Expo 2022 news: Prime Minister Narendra Modi on Thursday (June 9) said that his government believes in strengthening every sector for giving momentum to the country's development ...

Outlining the purpose behind establishing India's only vertically integrated cell and gene therapy facility, Dr. Krishna Ella, Executive Chairman, of Bharat Biotech, said, "Gene and cell therapies ...

In 2025, India is set to play a pivotal role in the global biotechnology revolution, with the first Bio-E3 policy already laying the foundation, says Dr. Jitendra Singh, Minister of State for ...

HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...

New Delhi: Developed by Bharat Biotech, India’s first intranasal Covid vaccine, on Tuesday got approval from DCGI for primary immunization against the infection for people above the age of 18.

A key topic of discussion was India’s biotechnology startup boom, with over 10,000 startups now operating in the sector. Dr. Singh pointed out that 70 per cent of these are focused on medical ...

PREMIUM Pharma (Representational image/Pixabay) With a strong foundation in research, innovation, and government support, India’s biotechnology sector has emerged as a critical player on the ...

The WHO said the products, manufactured by India's Marion Biotech, were "substandard" and that the firm had failed to provide guarantees about their "safety and quality." The alert issued on ...

Marion Biotech denies the allegations. After the deaths were reported in Uzbekistan, India's health ministry had suspended production at the company. On Wednesday, authorities in Uttar Pradesh ...